{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T10:48:09Z","timestamp":1758970089339,"version":"3.37.3"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,15]],"date-time":"2022-10-15T00:00:00Z","timestamp":1665792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,10,15]],"date-time":"2022-10-15T00:00:00Z","timestamp":1665792000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003010","name":"Ege \u00dcniversitesi","doi-asserted-by":"publisher","award":["TGA-2021-23122"],"award-info":[{"award-number":["TGA-2021-23122"]}],"id":[{"id":"10.13039\/501100003010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hormones"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s42000-022-00409-3","type":"journal-article","created":{"date-parts":[[2022,10,15]],"date-time":"2022-10-15T01:02:23Z","timestamp":1665795743000},"page":"61-69","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["High chitotriosidase and AGE levels in acromegaly: a case-control study"],"prefix":"10.1007","volume":"22","author":[{"given":"Hatice","family":"Ozisik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Banu Sarer","family":"Yurekli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asl\u0131","family":"Suner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oznur","family":"Copur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eser Y\u0131ld\u0131r\u0131m","family":"Sozmen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suha Sureyya","family":"Ozbek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmet Kas\u0131m","family":"Karabulut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilg\u0131n Y\u0131ld\u0131r\u0131m","family":"Simsir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet","family":"Erdogan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sevki","family":"Cetinkalp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fusun","family":"Saygili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,10,15]]},"reference":[{"key":"409_CR1","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.1210\/jcem.82.9.4257","volume":"82","author":"A Colao","year":"1997","unstructured":"Colao A, Merola B, Ferone D, Lombardi G (1997) Acromegaly. J Clin Endocrinol Metab 82:2777\u20132781","journal-title":"J Clin Endocrinol Metab"},{"key":"409_CR2","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1210\/er.2002-0022","volume":"25","author":"A Colao","year":"2004","unstructured":"Colao A, Ferone D, Marzullo P, Lombardi G (2004) Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev 25:102\u2013152","journal-title":"Endocr Rev"},{"key":"409_CR3","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/j.1365-2265.1994.tb03789.x","volume":"41","author":"C Rajasoorya","year":"1994","unstructured":"Rajasoorya C, Holdaway IM, Wrightson P, Scott DJ, Ibbertson HK (1994) Determinants of clinical outcome and survival in acromegaly. Clin Endocrinol (Oxf) 41:95\u2013102","journal-title":"Clin Endocrinol (Oxf)"},{"key":"409_CR4","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s11102-017-0827-5","volume":"20","author":"C Sch\u00f6fl","year":"2017","unstructured":"Sch\u00f6fl C, Petroff D, T\u00f6njes A, Grussendorf M, Droste M, Stalla G, Jaursch-Hancke C, St\u00f6rmann S, Schopohl J (2017) Incidence of myocardial infarction and stroke in acromegaly patients: results from the German Acromegaly Registry. Pituitary 20:635\u2013642","journal-title":"Pituitary"},{"key":"409_CR5","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1016\/j.ijcard.2012.11.109","volume":"167","author":"S Mosca","year":"2013","unstructured":"Mosca S, Paolillo S, Colao A, Bossone E, Cittadini A, Iudice FL, Parente A, Conte S, Rengo G, Leosco D, Trimarco B, Filardi PP (2013) Cardiovascular involvement in patients affected by acromegaly: an appraisal. Int J Cardiol 167:1712\u20131718","journal-title":"Int J Cardiol"},{"key":"409_CR6","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1530\/EJE-09-0945","volume":"162","author":"H Akutsu","year":"2010","unstructured":"Akutsu H, Kreutzer J, Wasmeier G, Ropers D, Rost C, M\u00f6hlig M, Wallaschofski H, Buchfelder M, Sch\u00f6fl C (2010) Acromegaly per se does not increase the risk for coronary artery disease. Eur J Endocrinol 162:879\u2013886","journal-title":"Eur J Endocrinol"},{"key":"409_CR7","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1046\/j.1365-2265.2003.01789.x","volume":"58","author":"JV Silha","year":"2003","unstructured":"Silha JV, Krsek M, Hana V, Marek J, Jezkova J, Weiss V, Murphy LJ (2003) Perturbations in adiponectin, leptin and resistin levels in acromegaly: lack of correlation with insulin resistance. Clin Endocrinol (Oxf) 58:736\u2013742","journal-title":"Clin Endocrinol (Oxf)"},{"key":"409_CR8","first-page":"598","volume":"9","author":"C \u00d8stergaard","year":"2002","unstructured":"\u00d8stergaard C, Johansen JS, Benfield T, Price PA, Lundgren JD (2002) YKL-40 is elevated in cerebrospinal fluid from patients with purulent meningitis. Clin Diagn Lab Immunol 9:598\u2013604","journal-title":"Clin Diagn Lab Immunol"},{"key":"409_CR9","doi-asserted-by":"publisher","first-page":"22817","DOI":"10.3390\/ijms141122817","volume":"14","author":"HL Wang","year":"2013","unstructured":"Wang HL, Hsiao PC, Tsai HT, Yeh CB, Yang SF (2013) Usefulness of plasma YKL-40 in management of community-acquired pneumonia severity in patients. Int J Mol Sci 14:22817\u201322825","journal-title":"Int J Mol Sci"},{"key":"409_CR10","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/978-981-13-7318-3_11","volume":"1142","author":"A Kumar","year":"2019","unstructured":"Kumar A, Zhang KYJ (2019) Human Chitinases: Structure, Function, and Inhibitor Discovery. Adv Exp Med Biol 1142:221\u2013251","journal-title":"Adv Exp Med Biol"},{"key":"409_CR11","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1253\/circj.72.71","volume":"72","author":"B Karadag","year":"2008","unstructured":"Karadag B, Kucur M, Isman FK, Hacibekiroglu M, Vural VA (2008) Serum chitotriosidase activity in patients with coronary artery disease. Circ J 72:71\u201375","journal-title":"Circ J"},{"key":"409_CR12","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1161\/01.ATV.0000089329.09061.07","volume":"23","author":"M Artieda","year":"2003","unstructured":"Artieda M, Cenarro A, Ga\u00f1\u00e1n A, Jeric\u00f3 I, Gonzalvo C, Casado JM, Vitoria I, Puzo J, Pocov\u00ed M, Civeira F (2003) Serum chitotriosidase activity is increased in subjects with atherosclerosis disease. Arterioscler Thromb Vasc Biol 23:1645\u20131652","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"409_CR13","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1515\/jpem-2013-0365","volume":"27","author":"T Kologlu","year":"2014","unstructured":"Kologlu T, Ucar SK, Levent E, Akcay YD, Coker M, Sozmen EY (2014) Chitotriosidase as a possible marker of clinically evidenced atherosclerosis in dyslipidemic children. J Pediatr Endocrinol Metab 27:701\u2013708","journal-title":"J Pediatr Endocrinol Metab"},{"key":"409_CR14","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.mrgentox.2007.04.003","volume":"631","author":"AL Ferreira","year":"2007","unstructured":"Ferreira AL, Salvadori DM, Nascimento MC, Rocha NS, Correa CR, Pereira EJ, Matsubara LS, Matsubara BB, Ladeira MS (2007) Tomato-oleoresin supplement prevents doxorubicin-induced cardiac myocyte oxidative DNA damage in rats. Mutat Res 631:26\u201335","journal-title":"Mutat Res"},{"key":"409_CR15","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1111\/j.1365-2265.2009.03685.x","volume":"72","author":"L Boero","year":"2010","unstructured":"Boero L, Cuniberti L, Magnani N, Manavela M, Yapur V, Bustos M, G\u00f3mez Rosso L, Mero\u00f1o T, Marziali L, Viale L, Evelson P, Negri G, Brites F (2010) Increased oxidized low density lipoprotein associated with high ceruloplasmin activity in patients with active acromegaly. Clin Endocrinol (Oxf) 72:654\u2013660","journal-title":"Clin Endocrinol (Oxf)"},{"key":"409_CR16","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.numecd.2005.05.003","volume":"15","author":"D Del Rio","year":"2005","unstructured":"Del Rio D, Stewart AJ, Pellegrini N (2005) A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress. Nutr Metab Cardiovasc Dis 15:316\u2013328","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"409_CR17","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/S0272-6386(00)70189-2","volume":"35","author":"DS Raj","year":"2000","unstructured":"Raj DS, Choudhury D, Welbourne TC, Levi M (2000) Advanced glycation end products: a nephrologist\u2019s perspective. Am J Kidney Dis 35:365\u2013380","journal-title":"Am J Kidney Dis"},{"key":"409_CR18","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1067\/mhj.2002.124865","volume":"144","author":"D Mukherjee","year":"2002","unstructured":"Mukherjee D, Yadav JS (2002) Carotid artery intimal-medial thickness: indicator of atherosclerotic burden and response to risk factor modification. Am Heart J 144:753\u2013759","journal-title":"Am Heart J"},{"key":"409_CR19","doi-asserted-by":"publisher","first-page":"3141","DOI":"10.1210\/jc.2009-2670","volume":"95","author":"A Giustina","year":"2010","unstructured":"Giustina A, Chanson P, Bronstein MD, Klibanski A, Lamberts S, Casanueva FF, Trainer P, Ghigo E, Ho K, Melmed S, Group AC (2010) A consensus on criteria for cure of acromegaly. J Clin Endocrinol Metab 95:3141\u20133148","journal-title":"J Clin Endocrinol Metab"},{"key":"409_CR20","doi-asserted-by":"publisher","first-page":"636","DOI":"10.4158\/EP.17.4.636","volume":"17","author":"L Katznelson","year":"2011","unstructured":"Katznelson L, Atkinson JL, Cook DM, Ezzat SZ, Hamrahian AH, Miller KK, Force AAT (2011) American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Acromegaly\u20132011 update: executive summary. Endocr Pract 17:636\u2013646","journal-title":"Endocr Pract"},{"key":"409_CR21","first-page":"741","volume":"32","author":"EY S\u00f6zmen","year":"1994","unstructured":"S\u00f6zmen EY, Tanyal\u00e7in T, Onat T, Kutay F, Erla\u00e7in S (1994) Ethanol induced oxidative stress and membrane injury in rat erythrocytes. Eur J Clin Chem Clin Biochem 32:741\u2013744","journal-title":"Eur J Clin Chem Clin Biochem"},{"key":"409_CR22","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s102380100003","volume":"1","author":"EY S\u00f6zmen","year":"2001","unstructured":"S\u00f6zmen EY, S\u00f6zmen B, Girgin FK, Delen Y, Azarsiz E, Erdener D, Ers\u00f6z B (2001) Antioxidant enzymes and paraoxonase show a co-activity in preserving low-density lipoprotein from oxidation. Clin Exp Med 1:195\u2013199","journal-title":"Clin Exp Med"},{"key":"409_CR23","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1172\/JCI117084","volume":"93","author":"CE Hollak","year":"1994","unstructured":"Hollak CE, van Weely S, van Oers MH, Aerts JM (1994) Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease. J Clin Invest 93:1288\u20131292","journal-title":"J Clin Invest"},{"key":"409_CR24","doi-asserted-by":"crossref","first-page":"597","DOI":"10.33549\/physiolres.930234","volume":"51","author":"M Kalousov\u00e1","year":"2002","unstructured":"Kalousov\u00e1 M, Skrha J, Zima T (2002) Advanced glycation end-products and advanced oxidation protein products in patients with diabetes mellitus. Physiol Res 51:597\u2013604","journal-title":"Physiol Res"},{"key":"409_CR25","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.2337\/dc22-S002","volume":"45","author":"ADAPP Committee","year":"2022","unstructured":"Committee ADAPP (2022) 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2022. Diabetes Care 45:S17\u2013S38","journal-title":"Diabetes Care"},{"key":"409_CR26","first-page":"87","volume":"23","author":"JP Bastard","year":"1997","unstructured":"Bastard JP, Grimaldi A, Jardel C, Porquet D, Bruckert E, Hainque B (1997) A simple index of insulin resistance. Diabetes Metab 23:87\u201388","journal-title":"Diabetes Metab"},{"key":"409_CR27","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1159\/000343145","volume":"34","author":"PJ Touboul","year":"2012","unstructured":"Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Bornstein N, Csiba L, Desvarieux M, Ebrahim S, Hernandez Hernandez R, Jaff M, Kownator S, Naqvi T, Prati P, Rundek T, Sitzer M, Schminke U, Tardif JC, Taylor A, Vicaut E, Woo KS (2012) Mannheim carotid intima-media thickness and plaque consensus (2004\u20132006-2011). An update on behalf of the advisory board of the 3rd, 4th and 5th watching the risk symposia, at the 13th, 15th and 20th European Stroke Conferences, Mannheim, Germany, 2004, Brussels, Belgium, 2006, and Hamburg, Germany, 2011. Cerebrovasc Dis 34:290\u2013296","journal-title":"Cerebrovasc Dis"},{"key":"409_CR28","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3758\/BF03193146","volume":"39","author":"F Faul","year":"2007","unstructured":"Faul F, Erdfelder E, Lang AG, Buchner A (2007) G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 39:175\u2013191","journal-title":"Behav Res Methods"},{"key":"409_CR29","unstructured":"Korolenko TA, Cherkanova MS (2009) [Chitotriosidase of human macrophages and mammalian chitinases: biological functions and abnormalities in pathology]. Vestn Ross Akad Med Nauk 39-45."},{"key":"409_CR30","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1136\/jim-2020-001595","volume":"69","author":"S Cetin Sanlialp","year":"2021","unstructured":"Cetin Sanlialp S, Nar G, Senol H (2021) Clinical significance of chitotriosidase in outpatients with advanced heart failure. J Investig Med 69:736\u2013741","journal-title":"J Investig Med"},{"issue":"2","key":"409_CR31","doi-asserted-by":"publisher","first-page":"263","DOI":"10.3390\/diagnostics11020263","volume":"11","author":"A Cuta\u0219","year":"2021","unstructured":"Cuta\u0219 A, Drugan C, Roman G, Rusu A, C\u0103tan\u0103 CS, Achima\u0219-Cadariu A, Drugan T (2021) Evaluation of chitotriosidase and neopterin as biomarkers of microvascular complications in patients with type 1 diabetes mellitus. Diagnostics (Basel) 11(2):263","journal-title":"Diagnostics (Basel)"},{"key":"409_CR32","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.2147\/COPD.S184097","volume":"14","author":"S Majewski","year":"2019","unstructured":"Majewski S, Tworek D, Szewczyk K, Kisza\u0142kiewicz J, Kurmanowska Z, Brzezia\u0144ska-Lasota E, Jerczy\u0144ska H, Antczak A, Piotrowski WJ, G\u00f3rski P (2019) Overexpression of chitotriosidase and YKL-40 in peripheral blood and sputum of healthy smokers and patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 14:1611\u20131631","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"409_CR33","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1042\/bj20020075","volume":"365","author":"AD Recklies","year":"2002","unstructured":"Recklies AD, White C, Ling H (2002) The chitinase 3-like protein human cartilage glycoprotein 39 (HC-gp39) stimulates proliferation of human connective-tissue cells and activates both extracellular signal-regulated kinase- and protein kinase B-mediated signalling pathways. Biochem J 365:119\u2013126","journal-title":"Biochem J"},{"key":"409_CR34","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1006\/bbrc.2001.5253","volume":"285","author":"F De Ceuninck","year":"2001","unstructured":"De Ceuninck F, Gaufillier S, Bonnaud A, Sabatini M, Lesur C, Pastoureau P (2001) YKL-40 (cartilage gp-39) induces proliferative events in cultured chondrocytes and synoviocytes and increases glycosaminoglycan synthesis in chondrocytes. Biochem Biophys Res Commun 285:926\u2013931","journal-title":"Biochem Biophys Res Commun"},{"key":"409_CR35","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s11102-014-0621-6","volume":"18","author":"C Ozkan","year":"2015","unstructured":"Ozkan C, Altinova AE, Cerit ET, Yayla C, Sahinarslan A, Sahin D, Dincel AS, Toruner FB, Akturk M, Arslan M (2015) Markers of early atherosclerosis, oxidative stress and inflammation in patients with acromegaly. Pituitary 18:621\u2013629","journal-title":"Pituitary"},{"key":"409_CR36","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1530\/EJE-12-0753","volume":"168","author":"J Verhelst","year":"2013","unstructured":"Verhelst J, Velkeniers B, Maiter D, Haentjens P, T\u2019Sjoen G, Rietzschel E, Corvilain B, Abrams P, Nobels F, Abs R, Bex M (2013) Active acromegaly is associated with decreased hs-CRP and NT-proBNP serum levels: insights from the Belgian registry of acromegaly. Eur J Endocrinol 168:177\u2013184","journal-title":"Eur J Endocrinol"},{"key":"409_CR37","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/j.1365-2265.2008.03323.x","volume":"70","author":"L Boero","year":"2009","unstructured":"Boero L, Manavela M, G\u00f3mez Rosso L, Insua C, Berardi V, Fornari MC, Brites F (2009) Alterations in biomarkers of cardiovascular disease (CVD) in active acromegaly. Clin Endocrinol (Oxf) 70:88\u201395","journal-title":"Clin Endocrinol (Oxf)"},{"key":"409_CR38","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1111\/j.1365-2265.2007.02986.x","volume":"67","author":"M Andreassen","year":"2007","unstructured":"Andreassen M, Vestergaard H, Kristensen L (2007) Concentrations of the acute phase reactants high-sensitive C-reactive protein and YKL-40 and of interleukin-6 before and after treatment in patients with acromegaly and growth hormone deficiency. Clin Endocrinol (Oxf) 67:909\u2013916","journal-title":"Clin Endocrinol (Oxf)"},{"key":"409_CR39","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1507\/endocrj.EJ17-0300","volume":"65","author":"M Ilhan","year":"2018","unstructured":"Ilhan M, Turgut S, Turan S, Demirci Cekic S, Ergen HA, Korkmaz Dursun G, Mezani B, Karaman O, Yaylim I, Apak MR, Tasan E (2018) The assessment of total antioxidant capacity and superoxide dismutase levels, and the possible role of manganese superoxide dismutase polymorphism in acromegaly. Endocr J 65:91\u201399","journal-title":"Endocr J"},{"key":"409_CR40","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0009-8981(03)00328-0","volume":"336","author":"S Yarman","year":"2003","unstructured":"Yarman S, Ozden TA, G\u00f6kku\u015fu C (2003) The evaluation of lipid peroxidation and acute effect of octreotide on lipid peroxidation in patients with active acromegaly. Clin Chim Acta 336:45\u201348","journal-title":"Clin Chim Acta"},{"key":"409_CR41","first-page":"314","volume":"45","author":"P Anagnostis","year":"2013","unstructured":"Anagnostis P, Efstathiadou ZA, Gougoura S, Polyzos SA, Karathanasi E, Dritsa P, Kita M, Koukoulis GN (2013) Oxidative stress and reduced antioxidative status, along with endothelial dysfunction in acromegaly. Horm Metab Res 45:314\u2013318","journal-title":"Horm Metab Res"},{"key":"409_CR42","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1177\/153537020222700203","volume":"227","author":"HM Brown-Borg","year":"2002","unstructured":"Brown-Borg HM, Rakoczy SG, Romanick MA, Kennedy MA (2002) Effects of growth hormone and insulin-like growth factor-1 on hepatocyte antioxidative enzymes. Exp Biol Med (Maywood) 227:94\u2013104","journal-title":"Exp Biol Med (Maywood)"},{"key":"409_CR43","doi-asserted-by":"publisher","first-page":"3174","DOI":"10.1210\/jcem.87.7.8643","volume":"87","author":"G Brevetti","year":"2002","unstructured":"Brevetti G, Marzullo P, Silvestro A, Pivonello R, Oliva G, di Somma C, Lombardi G, Colao A (2002) Early vascular alterations in acromegaly. J Clin Endocrinol Metab 87:3174\u20133179","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Hormones"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-022-00409-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s42000-022-00409-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-022-00409-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,5]],"date-time":"2024-10-05T21:07:40Z","timestamp":1728162460000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s42000-022-00409-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,15]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["409"],"URL":"https:\/\/doi.org\/10.1007\/s42000-022-00409-3","relation":{},"ISSN":["1109-3099","2520-8721"],"issn-type":[{"type":"print","value":"1109-3099"},{"type":"electronic","value":"2520-8721"}],"subject":[],"published":{"date-parts":[[2022,10,15]]},"assertion":[{"value":"11 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Ethics Committee of Ege University Faculty of Medicine, \u0130zmir, Turkey (21-7T\/51).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"We obtained informed consent from the patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}